Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide day 1 side effects are usually mild and short-lived. Most people feel nothing beyond a little discomfort at the injection site, though some notice nausea or fatigue within hours of their first dose. That's normal biology, not a warning sign — your body is meeting a new medicine for the first time. Tirzepatide is a prescription-only medicine; a prescriber assesses whether it's right for you before treatment begins, including talking through what you might feel in the early days.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) that are involved in appetite signals and the pace at which food moves through your digestive system. On day 1, your body hasn't adjusted to that slower gastric emptying. Food sits a little longer in the stomach than it normally would, which is precisely why nausea is the most common early experience. It's the mechanism doing its job, not something going wrong.
The 2.5 mg starting dose is chosen because it gives your system the gentlest possible introduction. The NHS medicines page for tirzepatide confirms that nausea, vomiting, diarrhoea and indigestion are the most frequently reported reactions, with the sharpest likelihood of appearing when treatment starts or a dose changes. On day 1 at 2.5 mg, most people find any effect is brief and manageable. A smaller number feel nothing at all.
Injection-site redness or mild soreness is also common and usually fades within an hour or two. Rotating the injection site (between the abdomen, thigh and upper arm) helps reduce that over time. Your Patient Information Leaflet covers this in detail, and it's worth reading before your first injection rather than after.
Mild nausea, a general sense of fullness even if you haven't eaten much, loose stools or constipation, burping and light-headedness are all in the category of expected and self-limiting. Eating smaller portions, staying well hydrated and avoiding fatty or rich foods on injection day can make a real difference. Many people find these effects have already eased by day 3, you can read more about that window in our guide to how symptoms tend to change around day 3.
Some things shouldn't be managed at home. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. The symptom to act on is severe, persistent abdominal pain (particularly if it radiates towards the back) with or without vomiting. That is not typical first-day nausea. Go to A&E or call 999 if pain is severe. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing) also need immediate emergency care.
Dehydration is a quieter risk: if nausea or diarrhoea is significant, sip fluids consistently throughout the day. If you can't keep fluids down, contact your prescriber or 111. Our broader guide to tirzepatide side effects covers the full picture beyond day 1.
Mounjaro is the UK brand name for tirzepatide, they are the same medicine, so day 1 is the same experience regardless of which name you see on the box. If you've searched specifically for Mounjaro day-1 side effects, the answer is identical to what this page describes. The pre-filled KwikPen arrives cold (it's stored refrigerated) and should be allowed to reach room temperature for around 30 minutes before injecting, which also tends to reduce injection-site discomfort. Our full guide to Mounjaro side effects goes into greater depth on what to expect across the course of treatment, and is worth reading alongside your Patient Information Leaflet, or the electronic Medicines Compendium where the full Mounjaro SmPC is published.
When a pen arrives from our pharmacy it comes in plain, unbranded packaging via DPD with a tracking notification, so you're not left wondering whether it's going to turn up. That predictability matters when you're planning around a first injection.
Most day-1 effects don't need clinical input. But there are clear triggers for getting in touch: symptoms that feel disproportionately severe, nausea or vomiting that hasn't improved after 24–48 hours, an inability to eat or drink anything, or any symptom that simply doesn't feel right to you. If you're noticing symptoms that appeared specifically on your second day, our page on what to expect from Mounjaro day 2 side effects may help you work out whether what you're experiencing is typical. Our page covering side effects from tirzepatide more broadly can also help you put individual symptoms in context before deciding whether to call. A prescriber can advise on practical steps, and in some cases a slower titration approach is considered.
At nume, aftercare is available seven days a week, questions don't have to wait for a weekday. Our clinical team includes GPhC-registered Independent Prescribers who review every consultation personally. If you haven't started treatment yet and you'd like to talk through what to expect, the free consultation is the right starting point. You can also read through our FAQs for common questions patients ask before and after their first dose. Speak to our prescribers through the treatment consultation page, they address suitability and side effects as part of that first conversation, not as an afterthought.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.